Adage Capital Partners GP »

Arbutus Biopharma shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.7M 3.0M 2.58

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Morgan Stanley
Two Seas Capital
Vanguard Group
FourWorld Capital Management
Woodline Partners
Hudson Bay Capital Management
Adage Capital Partners GP
Geode Capital Management
Citadel Advisors
ADAR1 Capital Management
BlackBarn Capital Partners
Centiva Capital
Squarepoint Ops

View all funds holding Arbutus Biopharma